Sanguine
Sanguine Biosciences, a US-based leader in in-home specimen collection, digital health innovation, and patient-focused research support.
Founded
2010Sanguine Biosciences, a US-based leader in in-home specimen collection, digital health innovation, and patient-focused research support.
Founded in Sherman Oaks, United States, Sanguine Biosciences is dedicated to revolutionizing the field of medical research through in-home specimen collection and digital health innovation. Their core mission is to facilitate patient-focused research by partnering with researchers to design studies that support complex patient inclusion/exclusion criteria. Sanguine offers a range of services including mobile biospecimen collection, longitudinal sampling, and patient data acquisition, focusing on making it easier for patients to participate in clinical research from the comfort of their homes.
Sanguine has garnered attention for its innovative approach and has formed partnerships with leading research institutions and pharmaceutical companies. Notable figures in the biotech and healthcare sectors are affiliated with Sanguine, contributing to its credibility and growth. The company has achieved significant milestones in patient recruitment and data collection, positively impacting the efficiency and scope of clinical studies. Through its patient-centric model, Sanguine is transforming how medical research is conducted, making it more inclusive and accessible.
Companies similar to Sanguine include iSpecimen, Tasso, Sanguis and Conversant Bio.
Sanguine was founded in 2010.
Sanguine's headquarters is located in Los Angeles, CA, US.
Sanguine's most recent funding round was for $6M (USD) in October 2023.
As of Oct 31, 2023, Sanguine has disclosed funding of $12.2M (USD). Undisclosed round amounts are excluded.
Sanguine has 147 employees as of Feb 4, 2024.
Conversant Bio
